Introduction {#s01}
============

Nonlymphoid tissues (NLTs) that have experienced infections are subsequently surveyed by at least two subpopulations of memory T cells: tissue-resident memory T cells (T~RM~ cells) and effector memory T cells (T~EM~ cells). T~RM~ cells are now recognized as a majority of memory T cells in the NLTs ([@bib49]), spending their lifetimes within the NLTs without recirculation ([@bib10]; [@bib34]; [@bib55]; [@bib15]; [@bib51]; [@bib22]) and conferring rapid and robust protective immunity upon secondary pathogen invasion ([@bib10]; [@bib22]; [@bib29]; [@bib46]). Most CD8^+^ T~RM~ cells patrol epithelial layers, a frontline of the mucosa ([@bib11]; [@bib3]), where they serve as both initiators/enhancers of local immune responses in an antigen (Ag)-specific manner and as cytotoxic cells ([@bib43], [@bib44]; [@bib4]). In contrast, most CD4^+^ T~RM~ cells are present below the basement membrane (e.g., dermis) and generally form clusters, consistent with their functional role as helper cells ([@bib11]; [@bib19]; [@bib53]). In the case of skin, intestine, and vagina, several developmental cues for differentiation into T~RM~ cells have been reported, such as local activation and cytokine signals for the up-regulation of CD69 and down-regulation of sphingosine 1--phosphate receptor 1 (S1P~1~; [@bib34]; [@bib48]; [@bib5]; [@bib31]), TGF-β signals for up-regulation of another key T~RM~ cell marker, CD103, and down-regulation of T-box transcription factors ([@bib61]; [@bib32]) and IL-15 to promote survival ([@bib30], [@bib32]). A recent study has also revealed that, after acquisition of these local tissue-specific signals, cells committed to become T~RM~ cells up-regulate Hobit and Blimp-1 that serve as transcriptional programing of tissue residency ([@bib33]). Thus, the entry of effector cells into the epithelial tissues is an initial and pivotal checkpoint in the development of T~RM~ cells. Based on this, experimentally induced recruitment of cells into the epithelial tissues by Ag-independent local inflammation or topical chemokine administration has been shown to be sufficient for the establishment of T~RM~ cells, a method known as a prime-pull strategy ([@bib29]; [@bib46]). In contrast to T~RM~ cells, T~EM~ cells are defined as nonresident memory T cells present in the NLTs that circulate between NLTs and the blood stream ([@bib42]).

It is thought that CD8^+^ T~RM~ cells in the lung are distinct from T~RM~ cells in other peripheral sites in terms of their maintenance. After the resolution of respiratory virus infections, large numbers of Ag-specific memory CD8^+^ T cells persist in both the airways and the lung parenchyma (LP; [@bib16]; [@bib57]), and both populations can mediate substantial control of a secondary virus infection in the lungs ([@bib17]; [@bib7]; [@bib58]; [@bib35]). Memory CD8^+^ T cells in the airways that can be recovered by bronchoalveolar lavage show no evidence of recirculation, categorizing them as T~RM~ cells ([@bib8]). Because of the harsh airway environment, however, T cells in the airways have been shown to have a half-life of only 10--14 d ([@bib8]). Based on this, it has been proposed that the number of memory CD8^+^ T cells in the airways is maintained by continual recruitment from the systemic memory pool under steady-state conditions, rather than by prolonged survival or cytokine-driven homeostatic proliferation within the airway tissue ([@bib8]). Furthermore, previous studies have demonstrated that residual Ag remained in the lung-draining mediastinal LN (MLN) for several months after an acute respiratory infection ([@bib20], [@bib21]; [@bib60]; [@bib24]; [@bib50]), suggesting a model in which recent reactivation of memory CD8^+^ T cells by long-lived depots of viral Ag in the MLN is required for continual recruitment of memory CD8^+^ T cells to the airways ([@bib60]). This model was based on the observation that memory CD8^+^ T cells in the MLN and the lung showed a similar activation phenotype as determined by CD69. However, this model seemingly conflicted with a later study showing that CD69 must be down-regulated for egress of lymphocytes from the LNs ([@bib47]). Additionally, a large proportion of memory CD8^+^ T cells isolated from the LP have been shown to be contaminants from the lung vasculature (LV; [@bib1], [@bib2]). Thus, our understanding of memory CD8^+^ T cells in the LP has to be revised by using intravascular (i.v.) staining to distinguish cell population in the LV from those in the actual LP.

Here, we have comprehensively analyzed lung-resident memory CD8^+^ T cells using parabiosis and i.v. staining and definitively show that CD8^+^ T~RM~ cells in the lung are not maintained through the continual recruitment of new cells. Instead, we identify for the first time the presence of specific niches for the maintenance of CD8^+^ T~RM~ cells in the lung. These niches are found primarily in the lung interstitium (LI) with partial extension to the LP (to precisely describe our histological observations, we refer to the previously adopted term LP as LI/LP hereafter). These T~RM~ niches are distinct from conventional inducible bronchus-associated lymphoid tissue (iBALT) but are associated with tissue remodeling after injury. Based on our observations, we refer to the CD8^+^ T~RM~ niches as repair-associated memory depots (RAMDs). We further demonstrate differential roles of CD69 in generation and maintenance of CD8^+^ T~RM~ cells in the lung and an indispensability of a cognate Ag for successful establishment of CD8^+^ T~RM~ cells in the lung by a prime-pull strategy.

Results {#s02}
=======

Memory CD8^+^ T cells in the LI/LP and airways are not maintained by continual recruitment from the circulation {#s03}
---------------------------------------------------------------------------------------------------------------

i.n. infection with influenza virus A/HK-x31 (x31) induces populations of nucleoprotein (NP)-specific memory CD8^+^ T cells in the lung that exhibit typical T~RM~ phenotypes (CD69^+^CD49a^+^CD103^+^; [Fig. 1 A](#fig1){ref-type="fig"}). By using i.v. staining ([@bib1]) coupled with parabiosis that provides a continual supply of cells from the congenically marked partner through shared circulation, we first reevaluated the previously established concept that memory CD8^+^ T cells in the lung are continuously replenished by cells recruited from the circulation ([Fig. 1 B](#fig1){ref-type="fig"}). Complete equilibration of host- and partner-derived Ag-specific memory CD8^+^ T cells in the spleen and LV was observed 2 wk after the surgery. However, partner cells comprised only ∼20% in the MLN, LI/LP, and airways ([Fig. 1 C](#fig1){ref-type="fig"}), indicating reduced recruitment or retention of partner cells in the presence of host T~RM~ cells in these tissues. A critical difference between host and partner cells in these tissues was the expression of CD69, as unlike host cells, most of the partner-derived, virus-specific memory CD8^+^ T cells in the MLN, LI/LP, and airways were not reactivated, presumably despite the presence of residual Ag ([Fig. 1 D](#fig1){ref-type="fig"}). Almost all NP-specific CD69^+^ cells in MLN, LI/LP, and airways were host derived ([Fig. 1 E](#fig1){ref-type="fig"}), suggesting the role of reactivation in the retention of host memory CD8^+^ T cells ([@bib45]; [@bib31]). Furthermore, although host memory CD8^+^ T cells in the LI/LP were markedly skewed toward T~RM~ phenotypes, most partner cells lacked expression of CD49a and CD103 ([Fig. 1 F](#fig1){ref-type="fig"}). Collectively, the data suggest that memory CD8^+^ T cells in the LI/LP and airways consist of two distinct populations: a major (∼80%) population of T~RM~ cells that expresses a highly activated phenotype and a minor (∼20%) population of peripheral tissue-circulating T~EM~ cells which have not been recently reactivated by Ag.

![**Continual recruitment-independent maintenance of lung-resident CD8^+^ T cells.** (A) Expression of CD49a, CD103, and CD69 on NP~366--374~/D^b+^ CD8^+^ T cells in each tissue at day 30 after i.n. infection with x31. (B) Congenic mice were infected i.n. with x31 and were subjected to parabiotic surgery 30 d later. Mice were analyzed on day 14 after the surgery unless otherwise specified. (C) Host/partner ratios of NP-specific CD8^+^ T cells in each tissue. (D) Ratios of CD69^+^ cells among host and partner NP-specific CD8^+^ T cells in each tissue. (E) Host/partner ratios of CD69^+^ NP-specific CD8^+^ T cells in each tissue. (F) Expression of the indicated molecules on host and partner NP-specific CD8^+^ T cells in the LI/LP. (G) Host/partner ratios of NP-specific CD8^+^ T cells in each tissue at day 79 after the surgery. (H) Host/partner ratios of NP-specific CD8^+^ T cells in each tissue of x31-immune mice depleted of Thy1.1^+^ cells 1 d before parabiosis. Data are representative of three independent experiments (mean and SEM of four to five pairs of mice). \*\*\*\*, P \< 0.0001 by two-way ANOVA with Bonferroni's posthoc tests (C and D), two-way repeated measures ANOVA with Sidak's posthoc tests (E), and Student's *t* test in comparison with each counterpart in [Fig. 1 C](#fig1){ref-type="fig"} (G and H).](JEM_20160938_Fig1){#fig1}

We considered the possibility that continual recruitment from the circulation would take longer than the 2-wk time frame used in the prior parabiosis experiments. However, we detected no significant increase in the ratio of partner cells in the MLN, LI/LP, and airways even after 7 wk of parabiosis (compare [Fig. 1, C and G](#fig1){ref-type="fig"}). These data contradict previous assumptions about the recruitment of memory and suggest that neither LI/LP nor airway-resident memory CD8^+^ T cells are maintained through continual recruitment from systemic circulation. We confirmed this conclusion by joining x31-immune pairs, of which circulating, but not resident, memory CD8^+^ T cells of one parabiont were depleted with CD90.1 (Thy1.1)-specific antibody just before surgery. 2 wk after surgery, most of the memory CD8^+^ T cells in the circulation (spleen and LV) of Thy1.1 parabionts were replaced by C57BL/6 (B6)-derived cells ([Fig. 1 H](#fig1){ref-type="fig"}). However, loss of circulating Thy1.1 cells had no impact on the ratio of those in the LI/LP and airways of Thy1.1 hosts (compare [Fig. 1, C and H](#fig1){ref-type="fig"}, left). These results clearly demonstrate that maintenance of memory CD8^+^ T cells in the lung tissues does not require recruitment of new cells from the circulation.

Reduced accumulation of *Cd69^−/−^* CD8^+^ T cells in the lung {#s04}
--------------------------------------------------------------

The long term retention of CD8^+^ T~RM~ cells in the lungs suggests that CD49a and CD103 play a key role in this process because the adhesive functions of these molecules has been well established ([@bib40]; [@bib28]). In contrast, the potential role of CD69 in the maintenance of CD8^+^ T~RM~ cells in the lung is unclear ([@bib53]). To address this issue, we investigated whether *Cd69^−/−^* CD8^+^ T cells can be maintained in the lung after x31 infection. When WT and *Cd69^−/−^* mice were infected with x31, comparable levels of CD8^+^ T cell expansion and memory formation were observed in the spleen of both mice, with only a modest decrease in the number of Ag-specific effector as well as memory CD8^+^ T cells in the LI/LP and airways in the *Cd69^−/−^* mice ([Fig. 2 A](#fig2){ref-type="fig"}). However, when the tissue distributions of WT and *Cd69^−/−^* CD8^+^ T cells were compared in mixed BM chimeric mice, where the relative migration and retention of cells from the two donors can be directly compared, the ratio of virus-specific *Cd69^−/−^* CD8^+^ T cells in the LI/LP and airways relative to WT counterparts was greatly reduced ([Fig. 2 B](#fig2){ref-type="fig"}). This was true during both the acute and late phases of infection, suggesting that *Cd69^−/−^* CD8^+^ T cells are less competitive in accumulating in these tissues. Nevertheless, the absence of CD69 had little if any influence on the expression of other potential adhesion molecules, such as CD49a and CD103, on virus-specific CD8^+^ T cells in the LI/LP and airways ([Fig. 2 C](#fig2){ref-type="fig"}). Moreover, relative reduction in the proportion of *Cd69^−/−^* CD8^+^ T cells in the LI/LP and airways of BM chimeras was unlikely to be caused by poor survival of these cells, as comparable expression of the prosurvival protein Bcl-2, annexin V binding, and 7-AAD incorporation at the peak of infection were observed on both WT and *Cd69^−/−^* CD8^+^ T cells ([Fig. 2, D and E](#fig2){ref-type="fig"}). These results suggest that CD69 itself may directly influence the accumulation of CD8^+^ T cells in the lung during the early phase of infection.

![**Reduced accumulation of *Cd69^−/−^*/CD8^+^ T cells in the lung compared with CD69^+^/CD8^+^ T cells.** (A) Numbers of NP-specific CD8^+^ T cells in each tissue of WT or *Cd69^−/−^* mice at day 10 and 30 after i.n. infection with x31. (B--E) Mice were treated with busulfan and 24 h later were injected with a 1:1 mixture of WT and *Cd69^−/−^* BM cells. 6 wk later, these mice were infected i.n. with x31. (B) Ratios of *Cd69^−/−^* cells among donor NP-specific CD8^+^ T cells in each tissue at day 10 and 30 PI. Lines connect data from each individual recipient mouse. (C) Ratios of CD49a^+^ and CD103^+^ cells among NP-specific CD8^+^ T cells in each tissue at the indicated time points. (D) Ratios of 7-AAD^+^annexin V^+^ cells among NP-specific CD8^+^ T cells in each tissue at day 30 PI. (E) Representative histograms showing Bcl-2 expression in WT (black lines) and *Cd69^−/−^* (gray lines) NP-specific CD8^+^ T cells in each tissue at day 30 PI. Data are representative of two independent experiments (mean and SEM of three to five mice per group). \*\*\*, P \< 0.001 by two-way repeated measures ANOVA with Sidak's posthoc tests (A and C), one-way repeated measures ANOVA with Tukey's posthoc tests (B), and Student's *t* test (D).](JEM_20160938_Fig2){#fig2}

CD69-independent maintenance of CD8^+^ T~RM~ cells in the lung {#s05}
--------------------------------------------------------------

It has been previously established that S1P~1~ promotes the egress of effector CD8^+^ T cells from inflamed peripheral tissues ([@bib48]; [@bib31]) and that its activity is inhibited by CD69 ([@bib47]). Therefore, we speculated that the relative inefficiency in accumulation of *Cd69^−/−^* CD8^+^ T cells in the lung ([Fig. 2 B](#fig2){ref-type="fig"}) reflected increased egress from the tissues. To address this issue, we investigated whether FTY720, an agonist of S1P~1~, would replicate the data with *Cd69^−/−^* mice. Repeated injection of FTY720 for 12 d from the peak of infection resulted in a significant increase in the number of Ag-specific CD8^+^ T cells in the LI/LP and airways ([Fig. 3 A](#fig3){ref-type="fig"}, day 21). This was despite the fact that FTY720 also blocked extravasation of cells from the LNs, presumably a source of new effector CD8^+^ T cells during the early phase of infection ([Fig. 3 A](#fig3){ref-type="fig"}, see day 21, MLN and LV). These data confirmed that S1P~1~ plays a role in the egress of CD8^+^ T cells from the LI/LP. Importantly, the percentage of CD69^+^ cells among NP-specific CD8^+^ T cells decreased in the lung during the FTY720 treatment ([Fig. 3 B](#fig3){ref-type="fig"}), indicating that CD69^−^ cells, which committed to exit from the tissues, might mainly account for the increase of cells in the lung. In fact, when FTY720 treatment was discontinued, differences in the numbers of memory CD8^+^ T cells in the lung were no longer observed between treated and untreated groups ([Fig. 3 A](#fig3){ref-type="fig"}, day 37). Thus, the fact that *Cd69^−/−^* CD8^+^ T cells are less competitive than WT cells in accumulating in the lung ([Fig. 2 B](#fig2){ref-type="fig"}) indicates that the expression of CD69 enhances the retention of CD8^+^ T cells in the lung at least during the early phase of infection.

![**Differential roles of CD69 in the retention of circulatory and resident memory CD8^+^ T cells in the lung.** (A and B) Mice were infected i.n. with x31 and were treated for 13 consecutive days with FTY720 or the vehicle alone from day 9. (A) Numbers of NP-specific CD8^+^ T cells in each tissue at the indicated time points. (B) Ratios of CD69^+^ cells among NP-specific CD8^+^ T cells in each tissue at day 21 PI. (C and D) WT and *Cd69^−/−^* mice were infected i.n. with x31 and were parabiotically joined 30 d later. Mice were analyzed at day 14 after the surgery. (D) WT/*Cd69^−/−^* ratios among NP-specific CD8^+^ T cells in each tissue of *Cd69^−/−^* (left) and WT (right) parabionts. (E) Expression of the indicated genes in sorted CD69^+^ or CD69^−^ CD44^hi^CD8^+^ T cells in each tissue of WT mice at day 30 PI. (F) Expressions of CD49a and CD103 by NP-specific CD8^+^ T cells and those of CD69 by the indicated populations in the LI/LP of WT mice. (G) Expression of the indicated genes in sorted CD49a^+^CD103^+^ or CD49a^−^CD103^−^ CD44^hi^CD8^+^ T cells in each tissue of *Cd69^−/−^* mice at day 30 PI. (H) S1P-specific chemotaxis of activated and nonactivated NP-specific CD8^+^ T cells isolated from each tissue of WT or *Cd69^−/−^* mice at day 30 PI. Data are representative of two independent experiments (mean and SEM of three to six mice per group or three pairs of mice for parabiosis). \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 by two-way repeated measures ANOVA with Sidak's posthoc tests (A, E, and G), Student's *t* test in comparison with each counterpart in the [Fig. 1 C](#fig1){ref-type="fig"} (D), and two-way ANOVA with Bonferroni's posthoc tests (H).](JEM_20160938_Fig3){#fig3}

Next, we investigated whether the expression of CD69 is also essential for the maintenance of CD8^+^ T~RM~ cells in the lung. If this is the case, parabiosis of x31-immune *Cd69^−/−^* and WT mice should result in a decrease in the ratio of *Cd69^−/−^* CD8^+^ T~RM~ cells in the lungs of the *Cd69^−/−^* parabionts ([Fig. 3 C](#fig3){ref-type="fig"}). Surprisingly, ∼80% of *Cd69^−/−^* CD8^+^ T~RM~ cells still remained in the LI/LP and airways of *Cd69^−/−^* hosts at 2 wk after surgery ([Fig. 3 D](#fig3){ref-type="fig"}, left), comparable with the host cell percentages observed in WT pairs ([Fig. 1 C](#fig1){ref-type="fig"}). These results definitely demonstrate that CD8^+^ T~RM~ cells can be maintained in the LI/LP and airways independently of CD69. However, a lack of CD69 led to significant loss of CD8^+^ T~EM~ cells in the lung of the WT partner (compare [Fig. 1 C](#fig1){ref-type="fig"}, unshaded bars and [Fig. 3 D](#fig3){ref-type="fig"}, shaded bars, right). Collectively, the data strongly support a model in which S1P~1~-mediated egress and CD69-induced retention of CD8^+^ T cells within the lung play a key role in at least two stages: retention of effector CD8^+^ T cells during the early stages of infection and retention of CD8^+^ T~EM~ cells during the steady-state memory phase. However, once established, CD69 is no longer required for the retention of CD8^+^ T~RM~ cells in the lung.

Because both transcriptional down-regulation of S1P~1~ as well as the protein-level down-regulation through CD69-induced complex formation influence the egress of memory CD8^+^ T cells from the NLTs ([@bib48]), we next tested the possibility that S1P~1~ expression was transcriptionally down-regulated in CD8^+^ T~RM~ cells in the lung. At day 30 postinfection (PI), *Klf2* and its downstream target *S1pr1* were highly expressed in nonactivated (CD69^−^: mostly circulatory T~EM~ cells) cells in the lung, suggesting that transmigration of CD8^+^ T cells into the lung itself had little impact on the expression of these mRNAs ([Fig. 3 E](#fig3){ref-type="fig"}). In contrast, expressions of the *Klf2* and *S1pr1* were significantly down-regulated in reactivated (CD69^+^: mostly resident type) memory CD8^+^ T cells ([Fig. 3 E](#fig3){ref-type="fig"}). We obtained identical results using *Cd69^−/−^* memory CD8^+^ T cells, where reactivated and nonactivated cells were distinguished by their expression of CD49a and CD103 instead of CD69 ([Fig. 3, F and G](#fig3){ref-type="fig"}). These results suggest that CD69 may not be required for inhibiting the S1P~1~-mediated egress of CD8^+^ T~RM~ cells in the lung. Yet, in the case of T cell egress from the thymus and LN, CD69-mediated inhibition of S1P~1~ theoretically preceded transcriptional down-regulation of *S1pr1* ([@bib13]; [@bib6]; [@bib38]), explaining the nonredundant role of CD69 in T cell retention early after activation. Thus, we further examined whether reactivated *Cd69^−/−^* CD8^+^ T~RM~ cells in the lung still possess residual responsiveness to its ligand, S1P. As indicated by their reduced *S1pr1* mRNA expression, reactivated WT memory CD8^+^ T cells in the LI/LP showed no S1P-specific chemotactic activities, whereas their nonactivated counterparts, especially cells in the LI/LP, retained strong reactivity to S1P ([Fig. 3 H](#fig3){ref-type="fig"}, left). Importantly, genetic deletion of CD69 further enhanced S1P-specific chemotaxis of nonactivated (CD49a^−^CD103^−^) CD8^+^ T~EM~ cells in the LI/LP ([Fig. 3 H](#fig3){ref-type="fig"}, right). Despite their low expression levels of *S1pr1*, reactivated (CD49a^+^CD103^+^) *Cd69^−/−^* memory CD8^+^ T cells still retained their migratory responses to S1P ([Fig. 3 H](#fig3){ref-type="fig"}, right). Identical results were observed when activated and nonactivated CD8^+^ T cells of WT mice were separated by the expression of CD49a and CD103, the same method used for *Cd69^−/−^* mice (not depicted). These findings reinforced the concept that, in the absence of CD69, circulatory memory CD8^+^ T cells cannot stay in the LI/LP because of strong S1P-specific chemotaxis ([Fig. 3 D](#fig3){ref-type="fig"}, right) and provided conclusive evidence that *Cd69^−/−^* CD8^+^ T~RM~ cells in the LI/LP can be maintained even though these cells possess residual reactivity to S1P ([Fig. 3](#fig3){ref-type="fig"}, D, left, and H).

Distinct distributions of resident and circulatory memory CD8^+^ T cells in the lung {#s06}
------------------------------------------------------------------------------------

The stable retention of *Cd69^−/−^* CD8^+^ T~RM~ cells in the lung, despite their enhanced migratory potential, may be caused by limited exposure to the S1P gradient. Thus, we compared the distributions of T~RM~ and T~EM~ cells in the lungs in congenically distinct, x31-immune mice that were joined by parabiosis. This allowed us to distinguish T~RM~ and T~EM~ cells by using host- and partner-congenic markers, respectively ([Fig. 1 F](#fig1){ref-type="fig"}). After the resolution of infection, partially confluent foci of peribronchiolar cellular infiltrates with rather diffuse thickening of alveolar walls in surrounding areas were observed until at least 60 d PI ([Fig. 4, A and B](#fig4){ref-type="fig"}). Such peribronchiolar foci of lymphocytic infiltrates uniformly surrounded aggregates of cytokeratin-expressing basal cells, which were consistent with Krt pods generated in the process of bronchoalveolar regeneration after viral injuries ([Fig. 4 A](#fig4){ref-type="fig"}; [@bib26]; [@bib54]; [@bib62]). These peribronchiolar foci gradually shrank over time with minimum signs of residual fibrosis ([Fig. 2, B and C](#fig2){ref-type="fig"}). Host CD8^+^ T cells were detected predominantly in association with these regenerative foci, both within and around the Krt pods ([Fig. 4, D and E](#fig4){ref-type="fig"}). Many of the host T cells in such regions were also CD103^+^, suggesting that they were T~RM~ cells ([Fig. 4, F and G](#fig4){ref-type="fig"}). Consistent with previous studies ([@bib19]; [@bib53]), host CD4^+^ T cells were mainly found as clusters ([Fig. 5 A](#fig5){ref-type="fig"}, arrowheads). In most cases, host CD4^+^ T cell clusters surrounded B cell follicles, forming highly organized structures indicative of iBALT ([Fig. 5 B](#fig5){ref-type="fig"}). Although iBALT-like structures could be found in association with the dense lymphocytic infiltrates and some host CD8^+^ T cells also formed small clusters ([Fig. 5 A](#fig5){ref-type="fig"}, arrows), a greater part of peribronchiolar foci consisted of sequestered host CD8^+^ T cells that were distributed secluded from the iBALT structures ([Fig. 5, A and B](#fig5){ref-type="fig"}). Importantly, although potential lymphangiogenesis that accompanied tissue regeneration was observed within the peribronchiolar foci, CD8^+^ T~RM~ cells were clearly segregated from such lymphatic-rich regions ([Fig. 5 C](#fig5){ref-type="fig"}). In fact, a majority of host CD8^+^ T cells in the peribronchiolar foci distributed distant to lymph vessels as compared with those in the iBALT and unaffected LI ([Fig. 5 D](#fig5){ref-type="fig"} and Fig. S1). This spatial separation of T~RM~ cells from the lymphatics may explain the CD69-independent retention of cells despite residual reactivity to S1P ([Fig. 3 H](#fig3){ref-type="fig"}). In sharp contrast, donor-derived tissue-circulating CD8^+^ T~EM~ cells were rarely found in such peribronchiolar foci but were detected in the interstitium of thin-walled terminal/respiratory bronchioles and alveoli ([Fig. 4 D](#fig4){ref-type="fig"}), indicating distinct spatial distributions between CD8^+^ T~RM~ and T~EM~ cells in the lung. Note that although cells in the LV could also be detected in similar locations to CD8^+^ T~EM~ cells (Fig. S2; [@bib1]), a combination of parabiosis and i.v. staining enabled precise distinction between these cell populations ([Fig. 5 E](#fig5){ref-type="fig"}). Collectively, the data demonstrated a strict anatomical compartmentalization between resident and tissue/blood-circulating memory CD8^+^ T cells in the lung and apparent segregation of lung CD8^+^ T~RM~ cells into their specific niches, which are distinct from iBALT but are associated with the foci of tissue regeneration. Based on such unique features, we refer to the CD8^+^ T~RM~ niches in the lung as RAMDs.

![**CD8^+^ T~RM~ cells resided within the peribronchiolar foci in the LI/LP.** (A--G) Congenic mice were infected i.n. with x31 and were subjected to parabiotic surgery 18--22 d later. Mice were analyzed at day 14 after the surgery (day 32--36 PI). (A) Representative hematoxylin and eosin (H&E)--stained images of peribronchiolar foci (left) and pan-cytokeratin--expressing cell aggregates in the indicated section of the peribronchiolar foci (right). (B) Mean areas of peribronchiolar foci per sections. (C) Representative peribronchiolar foci in the lung stained with Masson's trichrome at day 30 PI. (D) Distributions of host (CD90.1^+^) and partner (CD90.2^+^) CD8^+^ T cells inside or outside of peribronchiolar foci. Pan-cytokeratin, green; CD90.1 or CD90.2, red; CD8, blue. Binary images of CD90.1^+^CD8^+^ or CD90.2^+^CD8^+^ cells were generated by using ImageJ software (right). Similar distributions of host and partner cells were also observed in the CD90.2^+^ parabionts. Line-shaped lymph vessels stained by anti-CD90 isoform antibodies were excluded ([@bib25]). Arrowheads indicate host (left) or partner (right) CD8^+^ T cells in the unaffected area. (E) Numbers of host and partner CD8^+^ T cells inside or outside of peribronchiolar foci. (F) Distributions of CD103^+^ host-derived T cells (Thy1^+^) inside or outside of peribronchiolar foci. Pan-cytokeratin, green; CD103, red; CD90.1, blue. (G) Numbers of CD103^+^CD90.1^+^ cells, and ratios of CD103^+^ cells among CD90.1^+^ cells inside or outside of peribronchiolar foci. Data are representative of two independent experiments (mean and SEM of six slides from at least four to five mice per group). (B, E, and G) \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 by Student's *t* test. Bars, 200 µm.](JEM_20160938_Fig4){#fig4}

![**Features of CD8^+^ T~RM~ niches in the LI/LP.** (A, C, and D) Congenic mice were infected i.n. with x31 and were subjected to parabiotic surgery 18--22 d later. Mice were analyzed at day 14 after the surgery (day 32--36 PI). (A) Representative CD8^+^ (arrowheads) and CD4^+^ (arrows) T cell clusters found in the peribronchiolar foci. Pan-cytokeratin, green; CD90.1, red; CD8 or CD4, blue. (B) Mice were infected i.n. with x31. Representative H&E-stained (left) and fluorescent (middle) micrographs of iBALT (top) and peribronchiolar foci (bottom) in the lung at day 30 PI. Pan-cytokeratin, green; B220, red; CD8, blue. (Right) Binary images of CD8^+^, CD4^+^, or B220^+^ cells were generated by using ImageJ software. Anti-CD4 antibody was stained using serial sections. (C) Representative fluorescence micrographs showing distributions of host (CD90.1^+^)-derived CD8^+^ T cells and lymph vessels (VEGFR-3^+^) inside (left and middle, serial sections) or outside (right) of peribronchiolar foci. (Left) Pan-cytokeratin, green; CD90.1, red; CD8, blue. (Middle and right) VEGFR-3, green; CD90.1, red; CD8, blue. Binary images of CD8^+^ cells were generated from the right micrographs. (D) Distances of host CD90.1^+^CD8^+^ cells from a closest VEGFR-3^+^ cell in the peribronchiolar foci. (E) Mice were injected i.v. with anti-CD8β antibody 3 min before tissue harvest. Shown are distributions of host (CD90.2^+^) and partner CD8^+^ T cells in the LI/LP. Pan-cytokeratin, green; CD8β (i.v.), red; CD8α, blue. Blue triangles indicate host cells in the LI/LP; CD8α^+^CD8β (i.v.)^−^CD90.2^+^. Red triangles indicate donor cells in the LI/LP; CD8α^+^CD8β (i.v.)^−^CD90.2^−^. Data are representative of two independent experiments (mean of six slides from at least four to five mice per group). \*\*\*\*, P \< 0.0001 by one-way ANOVA with Tukey's posthoc tests. Bars, 200 µm.](JEM_20160938_Fig5){#fig5}

CD8^+^ T cells recruited into the lung at the early stage of infection can differentiate to T~RM~ cells {#s07}
-------------------------------------------------------------------------------------------------------

We next investigated the kinetics by which the CD8^+^ T~RM~ population is established in the lung after infection. Pairs of mice infected at the same time were joined at various time points ([Fig. 6 A](#fig6){ref-type="fig"}), and the establishment of T~RM~ cells by partner cells (determined by equilibration of host and partner cells in the LI/LP and airways) was monitored at day 32 PI. Note that full chimerism was attained in the systemic circulation by day 10--14 after surgery (not depicted). Interestingly, successful establishment of partner CD8^+^ T~RM~ cells in the lung T~RM~ niche was observed when parabiosis was performed earlier, but not later, than day 6 PI ([Fig. 6 B](#fig6){ref-type="fig"}). Some pairs joined at day 2 PI showed relatively increased ratios of partner cells in the LI/LP and airways ([Fig. 6 B](#fig6){ref-type="fig"}). Acquisition of the T~RM~ phenotypes was also evident in partner cells in those pairs (compare [Fig. 1 F](#fig1){ref-type="fig"} and [Fig. 6 C](#fig6){ref-type="fig"}). These results suggest that cells recruited to the lung around the peak of CD8 T cell response (day 10--11 PI) may be involved in the lung T~RM~ niche, although a wide variation in donor cell ratios was observed depending on whether systemic equilibrium had been achieved by the time of harvest. As expected, only some of the parabiotic pairs joined at day 2 PI showed successful equilibrium in the spleen at day 11, and recruitment of partner cells to the lung was observed only in the pairs with significant splenic equilibrium ([Fig. 6 D](#fig6){ref-type="fig"}). Collectively, the data provided a critical turning point between resident and circulatory memory CD8^+^ T cells in the lung: distribution into the lung before the peak of cellular responses in this organ, which also parallels the peak of tissue damage necessary for creating the RAMDs, is essential for subsequent formation of CD8^+^ T~RM~ cells.

![**CD8^+^ T cells recruited to the lung at an early phase of infection gave rise to T~RM~ cells.** (A) Pairs of mice infected with x31 at the same time underwent the parabiotic surgery at various time points. Some pairs were joined before infection. Full equilibration of the host and partner CD8^+^ T cells in the blood was achieved ∼11--14 d after the surgery. (B) Host/partner ratios of NP-specific CD8^+^ T cells in each tissue at day 32 PI. Each symbol represents an individual mouse. (C) Expression of the indicated molecules on host and partner NP-specific CD8^+^ T cells in the LI/LP. (D) Host/partner ratios of NP-specific CD8^+^ T cells in each tissue at day 11 PI. Data are representative of two independent experiments (two pairs of mice).](JEM_20160938_Fig6){#fig6}

Local administration of cognate Ag is required for the establishment of CD8^+^ T~RM~ cells in the lung {#s08}
------------------------------------------------------------------------------------------------------

Given that acute recruitment of CD8^+^ T cells to the NLTs (e.g., skin and vagina) induced by Ag-independent inflammation or topical chemokine application enables local establishment of CD8^+^ T~RM~ cells ([@bib29]; [@bib46]), we investigated whether such a prime-pull strategy could also be applied to the lung. i.p. injection of a high-dose influenza virus led to the generation of substantial numbers of Ag-specific CD8^+^ T cells in the circulation accompanied by limited recruitment of them into the LI/LP and airways owing to the lack of productive pulmonary infection ([Fig. 7 A](#fig7){ref-type="fig"}; [@bib60]; [@bib50]). Low expressions of CD69, CD49a, and CD103 on i.p. primed memory CD8^+^ T cells in the LI/LP and airways revealed these to be CD8^+^ T~EM~ cells ([Fig. 7 B](#fig7){ref-type="fig"}). Using this model, we injected i.n. a toll-like receptor ligand, CpG oligodeoxynucleotide (ODN), to induce Ag-independent inflammation in the lung. At the peak of CpG ODN--induced inflammation in the lung, we observed considerably enhanced recruitment of i.p. primed, NP-specific effector CD8^+^ T cells in the LI/LP and airways ([Fig. 7 C](#fig7){ref-type="fig"}, day 11, gray bars). However, such increments in the numbers were no longer observed in the LI/LP and airways after the lung inflammation had resolved ([Fig. 7 C](#fig7){ref-type="fig"}, day 30, gray bars), indicating that, unlike other mucosal tissues, effector CD8^+^ T cells recruited to the lung by Ag-independent inflammation were unable to form T~RM~ cells. Interestingly, simultaneous administration of CpG ODN and cognate Ag led to massive acute recruitment of i.p. primed effector CD8^+^ T cells in the LI/LP and airways followed by significant retention of memory T cells even at a later time point ([Fig. 7 C](#fig7){ref-type="fig"}, unshaded bars). i.p. primed memory CD8^+^ T cells that remained in the lung had acquired typical T~RM~ phenotypes, which were not observed in cells after CpG ODN injection alone ([Fig. 7 D](#fig7){ref-type="fig"}). We further tested whether such a strategy could be applied even after memory CD8^+^ T cells were fully differentiated. As shown in [Fig. 7 (E and F)](#fig7){ref-type="fig"}, circulatory-to-resident conversion of memory CD8^+^ T cells in the LI/LP and airways was evident by local administration of CpG ODN plus cognate Ag but not by CpG ODN alone. Hence, not only inflammation-mediated recruitment, but also a cognate Ag is required for the formation of CD8^+^ T~RM~ cells in the lung. Notably, a single-shot administration of CpG ODN plus NP~366--374~ peptide alone without prior i.p. infection was unable to generate detectable levels of CD8^+^ T~RM~ cells in the lung, indicating that CD8^+^ T~RM~ cells detected in the lung were derived from cells elicited by i.p. infection with x31 ([Fig. 7 G](#fig7){ref-type="fig"}). We further considered the possibility that i.n. administration of NP peptide may lead to the expansion of i.p. primed, NP-specific CD8^+^ T cells in the MLN with a resultant increase in the numbers of cells in the circulation that can continue to seed the lung tissue. However, we did not see statistically significant increase in the numbers of NP-specific CD8^+^ T cells in both the MLN and the spleen even after i.n. administration with NP peptide ([Fig. 7, C and E](#fig7){ref-type="fig"}). In addition, analysis using Fucci transgenic (Tg) mice that can visualize real-time cell cycle progression by tracking two cell cycle--specific proteins, Cdt1 and Geminin ([@bib41]; [@bib52]), revealed that only small fractions of NP-specific CD8^+^ T cells in the MLN were in proliferative cycles after NP peptide administration ([Fig. 7 H](#fig7){ref-type="fig"}). These results indicate that CD8^+^ T cell encounter with the cognate Ag in the lung, but not in the MLN, is a key event for their conversion from circulatory to resident forms in the lung. Because of the critical relationship between local tissue damage and the formation of lung T~RM~ niches, we further speculated that local administration of an Ag in the presence of Ag-specific CD8^+^ T cells in the circulation causes certain tissue damage, the repairing of which subsequently creates the RAMDs that enables T~RM~ cell conversion. As expected, the peribronchiolar lymphocytic infiltrates surrounding Krt pods were observed exclusively in i.p. infected mice that received CpG ODN plus cognate Ag ([Fig. 8, A and B](#fig8){ref-type="fig"}). These results strongly support our findings that the recruitment of cells earlier than the peak of tissue damage is essential for the establishment of CD8^+^ T~RM~ cells ([Fig. 6](#fig6){ref-type="fig"}). We further tested whether bystander memory CD8^+^ T cells with a distinct specificity to the administered peptide could be involved in the T~RM~ cell pool in the lung through the damage repair process. We thus examined the numbers of acidic polymerase (PA)--specific CD8^+^ T cells in the settings of x31-prime (i.p.), NP peptide--pull (i.n.) strategy, the same method used in the experiments shown in [Fig. 7 C](#fig7){ref-type="fig"}. Although the addition of NP peptide had no impact on the CpG ODN--induced acute recruitment of PA-specific CD8^+^ T cells in the LI/LP and airways ([Fig. 8 C](#fig8){ref-type="fig"}, day 11), we observed a significant retention, albeit at a lower level, of PA-specific memory CD8^+^ T cells in the LI/LP, but not in airways, in mice injected i.n. with CpG ODN plus NP peptide ([Fig. 8 C](#fig8){ref-type="fig"}, day 30, unshaded bar), in which the RAMDs were created ([Fig. 8 A](#fig8){ref-type="fig"}). However, relative efficiency of T~EM~ to T~RM~ cell conversion (calculated by the ratio of Ag-specific CD8^+^ cells in the tissues per those in the spleen) exerted by NP-specific CD8^+^ T cells (Ag specific) was much higher than that by PA-specific (bystander) CD8^+^ T cells ([Fig. 8 D](#fig8){ref-type="fig"}; also see [Figs. 7 C](#fig7){ref-type="fig"} and [8 C](#fig8){ref-type="fig"}), suggesting that the sole recruitment of cells to the RAMDs may not be sufficient for the formation of T~RM~ cells. Importantly, PA-specific memory CD8^+^ T cells detected in the LI/LP did not show T~RM~ phenotypes ([Fig. 8 E](#fig8){ref-type="fig"}), indicating that the acquisition of T~RM~ phenotypes in the LI/LP depends on the local presence of relevant Ag. Collectively, these data suggest that although some bystander memory CD8^+^ T cells recruited to the LI/LP can be involved in the RAMDs, local Ag may be required for the optimal establishment of CD8^+^ T~RM~ cells in the LI/LP, acquisition of T~RM~ phenotypes, and subsequent recruitment of memory CD8^+^ T cells to the airways.

![**Prime-pull vaccination with a cognate Ag converted T~EM~ cells to T~RM~ cells in the lung.** (A--H) Mice were infected i.n. (A) or i.p. (A--E, G, and H) with x31. Some i.p. infected mice were then injected i.n. with PBS, CpG ODN, or CpG ODN + NP~366--374~ peptide at the indicated time points. (A) Numbers of NP-specific CD8^+^ T cells in each tissue at day 30 PI. (B) Ratios of CD69^+^, CD49a^+^, and CD103^+^ cells among NP-specific CD8^+^ T cells in the LI/LP and airways. (C) Numbers of NP-specific CD8^+^ T cells in each tissue at day 11 and 30 PI (day 3 and 22 after injection). (D) Expression of indicated molecules on NP-specific CD8^+^ T cells in the LI/LP and airways of mice shown in C at day 30 PI. (E) Numbers of NP-specific CD8^+^ T cells in each tissue at day 33 and 44 PI (day 3 and 14 after injection). (F) Expression of indicated molecules on NP-specific CD8^+^ T cells in the LI/LP and airways of mice shown in G at day 44 PI. (G) Uninfected mice and mice infected i.p. with x31 were injected i.n. with CpG ODN + NP~366--374~ peptide 8 d later as shown in C. Representative dot plots showing the binding of NP~366--374~/D^b^ tetramers on CD8^+^ T cells in the LI/LP mice at day 30 PI (day 22 after injection). (H) Fucci Tg mice were infected i.p. with x31 and then injected i.n. with CpG ODN or CpG ODN + NP~366--374~ peptide at day 8 PI. A group of x31-infected mice was challenged i.n. with PR8 at day 30 PI as a positive control to show the proliferating cells in the MLN. Expression of the Cdt1 and Geminin in NP-specific CD8^+^ T cells in the MLN of Fucci Tg mice at day 4 after treatment is shown. Numbers indicate the percentage of cells in each gate. Data are representative of two independent experiments (mean and SEM of five to six mice per group). \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 by Student's *t* test (A and B) and one-way ANOVA with Tukey's posthoc tests (C and E).](JEM_20160938_Fig7){#fig7}

![**Local Ag plays a role in the formation of CD8^+^ T~RM~ cells in the lung.** (A--E) Mice infected i.p. with x31 were then injected i.n. with PBS, CpG ODN, or CpG ODN + NP~366--374~ peptide at day 8 as shown in [Fig. 7 C](#fig7){ref-type="fig"}. (A) Representative H&E-stained (left) and fluorescent (right) micrographs of peribronchiolar foci in mice treated i.n. with CpG ODN + NP~366--374~ peptide at day 30 PI. Pan-cytokeratin, green; B220, red; CD8, blue. Similar infiltrates were not observed in mice treated i.n. with PBS or CpG alone. Bars, 200 µm. (B) Mean areas of peribronchiolar foci in the lung were measured in mice shown in A at day 30 PI. (C) Numbers of PA-specific CD8^+^ T cells in each tissue at day 11 and 30 PI (day 3 and 22 after treatment). (D) Ratio of tetramer^+^ cells in tissues relative to those in the spleen (\[\# tetramer^+^ cells in a tissue/\# tetramer^+^ cells in the spleen\] × 100) of mice treated i.n. with CpG ODN + NP~366--374~ peptide. (E) Representative dot plots showing the expression of indicated molecules on PA- and NP-specific CD8^+^ T cells in the LI/LP of mice treated with either PBS, CpG ODN, or CpG ODN + NP~366--374~ peptide. Data are representative of two independent experiments (mean and SEM of five to six mice per group). \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; \*\*\*\*, P \< 0.0001 by one-way ANOVA with Tukey's posthoc tests (B and C) and Student's *t* test (D).](JEM_20160938_Fig8){#fig8}

Discussion {#s09}
==========

In contrast to the skin, intestine, and vagina, the lung comprises a relatively ill-defined interstitium, which seems unsuitable for the long-term maintenance of T~RM~ cells. In this study, we show that lung-resident CD8^+^ T cells localized within the auxiliary developed specific niches as RAMDs. The RAMDs consist of peribronchiolar foci surrounding Krt pods, which are known to be created after regeneration of damaged tissue, and are distinct from conventional iBALT structures. Memory CD8^+^ T cells in the thin interstitium, however, are circulating T~EM~ cells that retain the expression of *S1pr1* and are driven to exit in response to S1P. The T~RM~ niches are occupied with T~RM~ precursors by the peak of CD8^+^ T cell responses in the lung and are no longer available for cells recruited later, such as T~EM~ cells. During this early period, WT CD8^+^ T cells have an advantage over *Cd69^−/−^* counterparts in reaching the T~RM~ niche because of their ability to inhibit S1P~1~-mediated tissue egress by CD69. Even though this process is relatively effective, it is not essential, as a majority of *Cd69^−/−^* CD8^+^ T cells can still give rise to T~RM~ cells when WT competitors are absent. Owing to the restricted availability of the CD8^+^ T~RM~ niche and its developmental relationship with the damage regeneration process, simple prime-pull strategy is unable to establish CD8^+^ T~RM~ cells in the lung. Instead, i.n. administration with trace amounts of cognate Ag in the presence of preformed circulating Ag-specific CD8^+^ T cells enables the creation of de novo T~RM~ niches, followed by the conversion from T~EM~ to T~RM~ cells.

Morphological changes of the bronchiolar/alveolar walls and the appearance of Krt pods in association with the peribronchiolar lymphocytic infiltrations are major hallmarks of the RAMD. In response to severe damage of the bronchiolar as well as alveolar epithelia, distal airway stem cells that express keratin 5 are activated, undergo rapid proliferation, and assemble at the damaged site (observed as Krt pods), where these cells differentiate and reconstruct the damaged lung tissues ([@bib26]; [@bib54]; [@bib62]). Because complete tissue recovery from such severe damage takes a couple of months ([@bib37]), it makes sense that CD8^+^ T~RM~ cells that are rapid responders to reinfections are committed to intensively defend such weak spots during this period. In contrast, CD4^+^ T~RM~ cells and memory B cells, cell populations that need to interact with each other for recall responses, are maintained mainly in the organized iBALT structures. Such CD8^+^ T~RM~ cell--specific niches regionally created at the site of injury are also observed in the skin ([@bib11]; [@bib59]). We suggest that the previously reported gradual decline in the numbers of CD8^+^ T~RM~ cells in the lung for the first couple of months PI could be accompanied by the wane in areas and numbers of RAMDs as tissue regeneration proceeds and that, after full reconstruction, some of the RAMDs may remain for an additional period like iBALT, but most of them will disappear. Such a transitional appearance of RAMDs may account for the relatively shorter longevity of CD8^+^ T~RM~ cell--mediated local protection in the lung as compared with those in other mucosa ([@bib58]).

In the case of iBALT, a sequence of developmental cues is known to be involved in the formation and maintenance of this lymphoid structure: T cell--derived IL-17 as an initiator followed by chemokines CXCL13 and CCL19 for the accumulation of T cells and B cells and lymphocyte- as well as DC-derived lymphotoxin for long-term maintenance ([@bib12]; [@bib14]; [@bib39]). Because the RAMDs in the lung have no apparent B cell follicles and resemble extended T cell areas of secondary lymphoid tissues, most of these factors, especially CXCL13 and CCL19, would not be required for their formation. Instead, it is conceivable that cells constituting such auxiliary developed regenerative tissues could be a source of unique factors necessary for differentiation and maintenance of T~RM~ cells, such as TGF-β ([@bib18]), CD4^+^ T cell--mediated indirect signals ([@bib27]), and cognate Ag ([@bib23]). Because persistent depots of viral Ag were specifically observed in the peribronchiolar foci ([@bib24]), Ag-presenting cells in the RAMDs may provide TCR-mediated tonic signals necessary for the acquisition of T~RM~ phenotypes ([@bib53]) and also for up-regulation of an antiviral molecule, IFITM3 ([@bib56]). Moreover, at an early phase of infection, these Ag-presenting cells may play a role in the selection of memory-precursor effector CD8^+^ T cells possessing high-affinity T cell receptors ([@bib9]). However, reactivation-induced up-regulation of CD69, the subsequent transcriptional down-regulation of *Klf2* and *S1pr1*, and segregation from lymph-rich areas in the RAMDs seem apparently redundant from the perspective of inhibiting S1P~1~-mediated egress. Thus, it is reasonable to assume that the activated phenotypes exhibited by CD8^+^ T~RM~ cells play an additional role other than simply promoting tissue retention. At present, the histological nature of putative CD8^+^ T~RM~ niches in the airways remains unclear. Considering the known short life span of airway CD8^+^ T~RM~ cells ([@bib8]), along with our current parabiosis data, we assume that CD8^+^ T~RM~ niches in the airways exist within the bronchiolar walls adjacent to those in the LI/LP and that the numbers of CD8^+^ T~RM~ cells in the airways are likely maintained by the continual recruitment of cells from the LI/LP but not from the circulation. Hence, residual Ag-driven reactivation of CD8^+^ T~RM~ cells in the LI/LP could be a driving force for the continual recruitment to the airways in close vicinity to the areas of tissue damage. Such possibilities will need to be addressed in future studies.

Materials and methods {#s10}
=====================

Mice, virus, infections, and treatments {#s11}
---------------------------------------

Influenza viruses x31 and A/PR8/34 (PR8) were grown, stored, and titered as previously described ([@bib20]). B6 mice were purchased from CLEA Japan, Inc. B6.PL-*Thy1^a^*/CyJ (CD90.1^+^) and B6.SJL-*Ptprc^a^ Pepc^b^*/BoyJ mice (CD45.1^+^) were purchased from The Jackson Laboratory. *Cd69^−/−^* mice (B6 background; [@bib36]) were provided by Toshinori Nakayama. Fucci Tg mice (B6 background; [@bib41]) were provided by M. Tomura. Mice (6--8 wk) were infected i.n. (300 EID~50~) or i.p. (10^4^ EID~50~) with x31. Some groups of mice were injected i.p. with 150 µg FTY720 (Cayman), i.n. with 1 µg CpG ODN (InvivoGen), or i.n. with 20 µg of flu NP~366--374~ peptide. All animal studies were approved by Kindai University.

Tissue harvest and flow cytometry {#s12}
---------------------------------

Mice were injected i.v. with 1 µg anti-CD8β 3 min before tissue harvest. Cells in the lung airways were recovered by lavage with 5 × 1 ml PBS, followed by plastic adherence for 1 h at 37°C. Lung tissues were digested by collagenase D (Roche) for 30 min at 37°C and enriched by centrifugation in 40/80% Percoll gradient. MLN and spleen cells were obtained by straining through nylon mesh and enriching by either plastic adherence (MLN) or panning on anti--mouse IgG--coated flasks, followed by RBC lysis in buffered ammonium chloride. Cells were blocked first with mAbs to FcRγIII/II and then stained with allophycocyanin-conjugated influenza NP~366--374~/D^b^ or PA~224--233~/D^b^ tetramer. Tetramer-labeled cells were washed and stained with fluorescence-conjugated reagents purchased from BD (CD45.1 and CD90.1), BioLegend (CD8α, CD8β, CD69, CD103, Bcl-2, and annexin V), TONBO Bioscience (CD90.2), or Beckman Coulter (7-AAD). Tetramers were generated by the Trudeau Institute Molecular Biology Core. Samples were run on LSRFortessa flow cytometers (BD), and data were analyzed using FlowJo software (Tree Star).

Mixed BM chimera {#s13}
----------------

Recipient mice were injected i.p. with 600 µg of busulfan (Otsuka Pharmaceutical). The next day, BM cells isolated from *Cd69^−/−^* and WT mice were mixed 1:1, and a total of 2--2.5 × 10^7^ cells were injected i.v. Chimeras were rested for 6 wk for reconstitution and were bled to confirm the presence of the donor CD8^+^ T cells before virus infection.

Parabiosis {#s14}
----------

Mice were anesthetized, and flank hair was removed with a clipper. A longitudinal skin incision was made from the knee to the elbow on a single lateral side along with a 1-cm lateral peritoneal incision. Two mice were joined together by suturing each reciprocal peritoneal opening. Two mattress stiches were made on the lateral edges of the skin section to hold the mice in the upright position, and the dorsal and ventral sides of the skin section of each mouse were further joined with wound clips. Blood was obtained from mice at 10 d after the surgery to confirm equilibration. In some experiments, Thy1.1 mice were injected i.p. with 250 µg anti-CD90.1 antibody (19E12) 1 d before surgery.

Chemotaxis assay {#s15}
----------------

Migration of CD8^+^ T cells of x31-infected mice was analyzed in Transwell chambers with 5-µm pore--size polycarbonate filters (Corning). 10^6^ cells were added to the upper chamber. An optimal concentration of 10^−8^ M S1P (Sigma-Aldrich) was prepared in the serum-free medium (Hybridoma-SFM Complete DPM; Gibco) and added to the lower chamber. After incubation at 37°C in 5% CO~2~ for 4 h, the number of cells in the upper and lower chambers was analyzed by flow cytometry. Percent migration was calculated as (\# cells in the lower chamber)/\[(\# cells in the upper chamber) + (\# cells in the lower chamber)\] × 100.

Real-time PCR {#s16}
-------------

At day 30 after x31 infection, CD69^+^ or CD69^−^ fractions of CD44^hi^CD8^+^ T cells in each tissue were sorted on a FACSAria flow cytometer (BD). Total RNA was prepared using an RNeasy Plus Mini kit (QIAGEN), and cDNA synthesis was performed by using a PrimeScript RT reagent kit (Takara Bio Inc.). Quantitative PCR was done on a real-time PCR system (Prism 7900HT; Thermo Fisher Scientific) in a 96-well plate format with SYBR green--based detection (Takara Bio Inc.). β-actin mRNA was used for normalization. The primers used were: KLF2 forward, 5′-TGTGAGAAATGCCTTTGAGTTTACTG-3′ and KLF2 reverse, 5′-CCCTTATAGAAATACAATCGGTCATAGTC-3′; and S1P~1~ forward, 5′-GTGTAGACCCAGAGTCCTGCG-3′ and S1P~1~ reverse, 5′-AGCTTTTCCTTGGCTGGAGAG-3′. mRNA levels in the thymocytes were used as a standard, and relative expression of mRNA was calculated as 2^−ΔCt^.

Immunofluorescence {#s17}
------------------

At day 18--22 after x31 infection, parabiosis was performed using B6 and Thy1.1 mice. 2 wk later, lung tissues were filled with 300 µl of optimal cutting temperature compound (Sakura) through the trachea, harvested, embedded in optimal cutting temperature compound, and frozen in liquid nitrogen. 6-µm--thick cryosections were fixed for 2 min with acetone/ethanol, blocked with Blocking One reagent (Nacalai Tesque), and stained with a mixture of antibodies against CD90.1 (BD), CD90.2 (TONBO Bioscience), CD8, CD4, CD103, B220, (BioLegend), pan-cytokeratin, and vascular endothelial growth factor receptor 3 (VEGFR-3; goat polyclonal; R&D Systems) for 30 min at 37°C. Sections were further incubated with secondary antibodies, mounted with Prolong Gold reagent (Thermo Fisher Scientific), and then photographed using a confocal microscope (C2si; Nikon). Cell numbers in each color were counted by ImageJ (National Institutes of Health). Distances of CD8^+^ T~RM~ cells from a closest lymph vessel were measured by NIS-Elements software (Nikon).

Statistical analysis {#s18}
--------------------

Statistical analysis was performed with Prism (GraphPad Software). Methods of comparison and corrections for multiple comparisons are indicated in each relevant figure legend.

Online supplemental material {#s19}
----------------------------

Fig. S1 shows representative fluorescence micrographs for measuring distances of CD8^+^ T~RM~ cells from lymph vessels in the lung. Fig. S2 shows representative fluorescence micrographs of i.v. staining, a method used in [Fig. 5 E](#fig5){ref-type="fig"}.
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